Specialty spend is on the rise again. This year's report details another double-digit increase (13.6%) in per member per year cost. Uncover what is driving increased spend and what you can do about it in this in-depth report. It unpacks everything you need to know about the state of specialty.


The fourth annual State of Specialty Spend and Trend Report analyzes specialty drug utilization and spending across 45 million pharmacy claims and 54 million medical claims. Our Artemetrx® platform integrates pharmacy and medical claims data to the individual patient level, enabling us to present a complete and unique view of specialty costs across all benefits.


Download your copy today!

How are you preparing for emerging specialty spend and trend?

PSG's fourth annual complete and unique view of integrated specialty costs across the medical and pharmacy benefit

Download the 2020 State of Specialty Spend and Trend Report

Here's a quick look at what you'll learn in our 2020 report

SPEND AND TREND

Take away many actionable items to help optimize your specialty spend as specialty costs continue to trend upward

HIGH-COST OUTLIER CLAIMS

Reduce specialty costs by identifying

high-cost outlier claims

DRUGS TO WATCH

Navigate the drug pipeline in 2020 and

beyond with a list of drugs to watch

BIOSIMILARS

Leverage the potential of biosimilars as

more biosimilars enter the market